These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 6408411

  • 1. Clinical and laboratory studies with selective monoamine-oxidase-inhibiting drugs. Implications for hypothesized neurotransmitter changes associated with depression and antidepressant drug effects.
    Murphy DL, Cohen RM, Siever LJ, Roy B, Karoum F, Wyatt RJ, Garrick NA, Linnoila M.
    Mod Probl Pharmacopsychiatry; 1983; 19():287-303. PubMed ID: 6408411
    [No Abstract] [Full Text] [Related]

  • 2. Studies of selective and reversible monoamine oxidase inhibitors.
    Mann JJ, Aarons SF, Frances AJ, Brown RD.
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):62-6. PubMed ID: 6429130
    [Abstract] [Full Text] [Related]

  • 3. Differential trace amine alterations in individuals receiving acetylenic inhibitors of MAO-A (clorgyline) or MAO-B (selegiline and pargyline).
    Murphy DL, Karoum F, Pickar D, Cohen RM, Lipper S, Mellow AM, Tariot PN, Sunderland T.
    J Neural Transm Suppl; 1998 Jul; 52():39-48. PubMed ID: 9564606
    [Abstract] [Full Text] [Related]

  • 4. New contributions from basic science to understanding the effects of monoamine oxidase inhibiting antidepressants.
    Murphy DL, Garrick NA, Aulakh CS, Cohen RM.
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):37-43. PubMed ID: 6735994
    [Abstract] [Full Text] [Related]

  • 5. [Effect of protein denaturing reactions on retardation of the activity of rat liver mitochondrial monoamine oxidase by clorgyline and deprenyl].
    Severina IS.
    Biokhimiia; 1983 Sep; 48(9):1513-21. PubMed ID: 6414536
    [Abstract] [Full Text] [Related]

  • 6. [Inhibition of gamma-amylase of the rabbit liver by biogenic amines and products of their oxidative deamination].
    Popova IA, Verevkina IV.
    Vopr Med Khim; 1983 Sep; 29(6):120-3. PubMed ID: 6422628
    [Abstract] [Full Text] [Related]

  • 7. Resiliency of monoaminergic systems: the 80% rule and its relevance to drug development.
    Blier P.
    J Psychopharmacol; 2008 Aug; 22(6):587-9. PubMed ID: 18753271
    [No Abstract] [Full Text] [Related]

  • 8. 2'-NH2-MPTP in Swiss Webster mice: evidence for long-term (6-month) depletions in cortical and hippocampal serotonin and norepinephrine, differential protection by selective uptake inhibitors or clorgyline and functional changes in central serotonin neurotransmission.
    Andrews AM, Murphy DL.
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1432-9. PubMed ID: 8263805
    [Abstract] [Full Text] [Related]

  • 9. Reciprocal changes in striatal dopamine and beta-phenylethylamine induced by reserpine in the presence of monoamine oxidase inhibitors.
    Juorio AV, Greenshaw AJ, Wishart TB.
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Dec; 338(6):644-8. PubMed ID: 3149722
    [Abstract] [Full Text] [Related]

  • 10. The effect of monoamine oxidase inhibitors on some arylalkylamines in rate striatum.
    Philips SR, Boulton AA.
    J Neurochem; 1979 Jul; 33(1):159-67. PubMed ID: 572413
    [No Abstract] [Full Text] [Related]

  • 11. Monoamine oxidase inhibitors--current status.
    Zemishlany Z, Radwan M, Wijsenbeek H.
    Isr J Psychiatry Relat Sci; 1983 Jul; 20(3):254-71. PubMed ID: 6325369
    [No Abstract] [Full Text] [Related]

  • 12. REM sleep suppression induced by selective monoamine oxidase inhibitors.
    Cohen RM, Pickar D, Garnett D, Lipper S, Gillin JC, Murphy DL.
    Psychopharmacology (Berl); 1982 Jul; 78(2):137-40. PubMed ID: 6817370
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of MAO-A activity enhances behavioural activity of rats assessed using water maze and open arena tasks.
    Barbelivien A, Nyman L, Haapalinna A, Sirviö J.
    Pharmacol Toxicol; 2001 Jun; 88(6):304-12. PubMed ID: 11453370
    [Abstract] [Full Text] [Related]

  • 14. [Mechanism of inhibition by chlorgyline and deprenyl of tyramine deamination by mitochondrial monoamine oxidase of rat liver].
    Deverina IS.
    Biokhimiia; 1980 Oct; 45(10):1897-908. PubMed ID: 6786369
    [Abstract] [Full Text] [Related]

  • 15. [Monoaminergic systems of the brain and behavior].
    Budantsev AIu, Azarashvili AA, Zharikov SI, Arkhipov VI.
    Usp Fiziol Nauk; 1977 Oct; 8(2):53-74. PubMed ID: 197724
    [No Abstract] [Full Text] [Related]

  • 16. [Disorders of oxidative deamination of biogenic amines in the myocardium in experimental atherosclerosis].
    Brusova EG, Krivchenkova RS.
    Vopr Med Khim; 1979 Oct; 25(2):198-204. PubMed ID: 442591
    [Abstract] [Full Text] [Related]

  • 17. [Effect of solubilization by methylethylketone of rat liver mitochondrial monoamine oxidase on inhibition by clorgyline and deprenyl of the enzyme activity].
    Severina IS, Klimova GI, Nersisian AA.
    Biokhimiia; 1981 Nov; 46(11):2043-55. PubMed ID: 6797482
    [Abstract] [Full Text] [Related]

  • 18. Depression: the case for a monoamine deficiency.
    Delgado PL.
    J Clin Psychiatry; 2000 Nov; 61 Suppl 6():7-11. PubMed ID: 10775018
    [Abstract] [Full Text] [Related]

  • 19. Effect of co-administration of subchronic lithium pretreatment and acute MAO inhibitors on extracellular monoamine levels and the expression of contextual conditioned fear in rats.
    Kitaichi Y, Inoue T, Nakagawa S, Izumi T, Koyama T.
    Eur J Pharmacol; 2006 Feb 27; 532(3):236-45. PubMed ID: 16487506
    [Abstract] [Full Text] [Related]

  • 20. Reversible monoamine oxidase-A inhibitors in resistant major depression.
    Nolen WA, Hoencamp E, Bouvy PF, Haffmans PM.
    Clin Neuropharmacol; 1993 Feb 27; 16 Suppl 2():S69-76. PubMed ID: 8313400
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.